Evaxion Biotech (NasdaqCM:EVAX) Q1 2026 Earnings call May 07, 2026 08:30 AM ET Company Participants Birgitte Rønø - Chief Scientific Officer and COO Helen Tayton-Martin - CEO Tania Vanmale - Associate Thomas Schmidt - CFO Conference Call Participants Michael Okunewitch - Senior Research Analyst Thomas Flaten - Senior Research Analyst Operator Good day. Thank you for standing by. Welcome to the Evaxion Business Update and First Quarter 2026 Financial Results Webcast and Conference Call. At this time, all par ...